DV
Dividend Vision

GNMX — Corgi Genomics & Precision Medicine ETF

Corgi Genomics & Precision Medicine ETF (GNMX)

GNMX carries a 0.35% expense ratio. Total return is 24.2% over the past 0.3 years, 18.1 points ahead of SPY at 6.1%.

Corgi Genomics & Precision Medicine ETF provides equity exposure to companies operating in the genomics and precision medicine sectors. The fund distributes income annually and carries an expense ratio of 0.35%. This ETF appeals to investors seeking exposure to healthcare innovation and scientific advancement rather than traditional income-focused strategies.

GNMX key facts

Issuer
Corgi Strategies
Asset type
ETF
Asset class
Equity
Inception date
05/05/2026
Expense ratio
0.35%
Distribution frequency
Annual
Last close
$31.94
AUM
$1,632,996
Average volume
1438.0